These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 8181159

  • 1. Redistribution of 99mTc-sestamibi and 201Tl in the presence of a severe coronary artery stenosis.
    Sinusas AJ, Bergin JD, Edwards NC, Watson DD, Ruiz M, Makuch RW, Smith WH, Beller GA.
    Circulation; 1994 May; 89(5):2332-41. PubMed ID: 8181159
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion.
    Beller GA, Glover DK, Edwards NC, Ruiz M, Simanis JP, Watson DD.
    Circulation; 1993 Jun; 87(6):2033-42. PubMed ID: 8504518
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction.
    Kauffman GJ, Boyne TS, Watson DD, Smith WH, Beller GA.
    J Am Coll Cardiol; 1996 Jun; 27(7):1592-7. PubMed ID: 8636541
    [Abstract] [Full Text] [Related]

  • 6. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile.
    Sinusas AJ, Trautman KA, Bergin JD, Watson DD, Ruiz M, Smith WH, Beller GA.
    Circulation; 1990 Oct; 82(4):1424-37. PubMed ID: 2401074
    [Abstract] [Full Text] [Related]

  • 7. Myocardial uptake and redistribution of 99mTc-N-NOET in dogs with either sustained coronary low flow or transient coronary occlusion: comparison with 201Tl and myocardial blood flow.
    Vanzetto G, Calnon DA, Ruiz M, Watson DD, Pasqualini R, Beller GA, Glover DK.
    Circulation; 1997 Oct 07; 96(7):2325-31. PubMed ID: 9337207
    [Abstract] [Full Text] [Related]

  • 8. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi.
    Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, Shea NL, Oates E, Konstam MA.
    Circulation; 1994 Jun 07; 89(6):2552-61. PubMed ID: 8205664
    [Abstract] [Full Text] [Related]

  • 9. Kinetics of technetium-99m-Sestamibi and thallium-201 in a transient ischemic myocardium animal model: insight into the 'redistribution' phenomenon.
    Mousa SA, Cooney JM, Stevens S.
    Cardiology; 1992 Jun 07; 81(2-3):157-63. PubMed ID: 1286474
    [Abstract] [Full Text] [Related]

  • 10. Relationship between regional myocardial blood flow and the distribution of 99mTc-sestamibi in the presence of total coronary artery occlusion.
    Mousa SA, Cooney JM, Williams SJ.
    Am Heart J; 1990 Apr 07; 119(4):842-7. PubMed ID: 2138845
    [Abstract] [Full Text] [Related]

  • 11. Myocardial 99mTc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis: comparison with 201Tl and regional myocardial blood flow.
    Glover DK, Ruiz M, Yang JY, Smith WH, Watson DD, Beller GA.
    Circulation; 1997 Oct 07; 96(7):2332-8. PubMed ID: 9337208
    [Abstract] [Full Text] [Related]

  • 12. Limitations of dobutamine for enhancing flow heterogeneity in the presence of single coronary stenosis: implications for technetium-99m-sestamibi imaging.
    Wu JC, Yun JJ, Heller EN, Dione DP, DeMan P, Liu YH, Zaret BL, Wackers FJ, Sinusas AJ.
    J Nucl Med; 1998 Mar 07; 39(3):417-25. PubMed ID: 9529285
    [Abstract] [Full Text] [Related]

  • 13. The effect of collateral flow and myocardial viability on the distribution of technetium-99m sestamibi in a closed-chest model of coronary occlusion and reperfusion.
    Chareonthaitawee P, O'Connor MK, Gibbons RJ, Ritman EL, Christian TF.
    Eur J Nucl Med; 2000 May 07; 27(5):508-16. PubMed ID: 10853805
    [Abstract] [Full Text] [Related]

  • 14. 99mTc-tetrofosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion.
    Glover DK, Ruiz M, Koplan BA, Watson DD, Beller GA.
    J Nucl Med; 1999 Jan 07; 40(1):142-9. PubMed ID: 9935070
    [Abstract] [Full Text] [Related]

  • 15. Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (SESTAMIBI).
    Li QS, Solot G, Frank TL, Wagner HN, Becker LC.
    J Nucl Med; 1990 Jun 07; 31(6):1069-76. PubMed ID: 2140856
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction.
    Koplan BA, Beller GA, Ruiz M, Yang JY, Watson DD, Glover DK.
    J Nucl Med; 1996 Aug 07; 37(8):1398-402. PubMed ID: 8708783
    [Abstract] [Full Text] [Related]

  • 18. Comparison of 99mTc-teboroxime with thallium for myocardial imaging in the presence of a coronary artery stenosis.
    Gray WA, Gewirtz H.
    Circulation; 1991 Oct 07; 84(4):1796-807. PubMed ID: 1914115
    [Abstract] [Full Text] [Related]

  • 19. Technetium-99m-labeled myocardial perfusion agents: Are they better than thallium-201?
    Kailasnath P, Sinusas AJ.
    Cardiol Rev; 2001 Oct 07; 9(3):160-72. PubMed ID: 11304401
    [Abstract] [Full Text] [Related]

  • 20. Myocardial uptake of thallium 201 and technetium 99m-labeled sestamibi after ischemia and reperfusion: comparison by quantitative dual-tracer autoradiography in rabbits.
    Weinstein H, Reinhardt CP, Wironen JF, Leppo JA.
    J Nucl Cardiol; 1994 Oct 07; 1(4):351-64. PubMed ID: 9420718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.